Associations between NOD2, IRGM and ORMDL3 polymorphisms and pediatric-onset inflammatory bowel disease in the Lithuanian population
Background and objective: Recent GWAS and meta-analyses have revealed about 200 susceptibility genes/loci for inflammatory bowel diseases (IBD). However, only a small number of studies were performed in early-onset IBD. The aim of this study was to assess the association between NOD2, IL23R, ATG16L1...
Main Authors: | Gitana Pranculienė, Rūta Steponaitienė, Jurgita Skiecevičienė, Rūta Kučinskienė, Gediminas Kiudelis, Kęstutis Adamonis, Liutauras Labanauskas, Limas Kupčinskas |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2016-01-01
|
Series: | Medicina |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1010660X16300878 |
Similar Items
-
Lemann Index for Assessment of Crohn’s Disease: Correlation with the Quality of Life, Endoscopic Disease activity, Magnetic Resonance Index of Activity and C- Reactive Protein
by: Straksyte Vestina, et al.
Published: (2019-11-01) -
Role of Mutations in NOD2/CARD15, ATG16L1, and IRGM in the Pathogenesis of Crohn’s Disease
by: Igor’ V. Maev, et al.
Published: (2014-03-01) -
Association of HFE gene C282Y and H63D mutations with liver cirrhosis in the Lithuanian population
by: Simonas Juzėnas, et al.
Published: (2016-01-01) -
LINE-1 hypomethylation is not a common event in preneoplastic stages of gastric carcinogenesis
by: Juozas Kupcinskas, et al.
Published: (2017-07-01) -
NOD2, CD14 and TLR4 mutations do not influence response to adalimumab in patients with Crohn's disease: a preliminary report Las mutaciones de NOD2, CD14 y TLR4 no influyen sobre la respuesta al adalimumab en pacientes con enfermedad de Crohn: informe preliminar
by: M. Barreiro-de Acosta, et al.
Published: (2010-10-01)